Solid Tumor Malignancy

• CLINICAL_TRIALS trial_result · 2024-08-27
  Clinical Trial Update: A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy [Phase 2]

  This Phase 2 trial assesses the safety and immunogenicity of the Moderna COVID-19 vaccine (mRNA-1273) in patients with solid tumors and hema…

• CLINICAL_TRIALS trial_result · 2020-06-09
  Clinical Trial Update: Phase 1/2a Dose-Escalation Study of CRLX301 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

  Phase 1/2a dose-escalation study of CRLX301 in patients with advanced solid tumors has been terminated; results posted in 2020.

• CLINICAL_TRIALS trial_result · 2015-04-03
  Clinical Trial Update: Scripps Tumorgraft Study

  The Scripps Tumorgraft study (NCT01726699) conducted by Scripps Translational Science Institute has completed. The trial investigated tumor …